AstraZeneca
Company Snapshot
Founded: 1999
Entity Type: Public
Employees: 94,300
Region: The Americas
Revenue: $54,073.0 Millions
Revenue Year: 2024
Segment: Oncology
Headquarter: Cambridge, U.K.
Key Geographics: The Americas, U.K., Rest of Europe, Asia, Africa, Australasia
Corporate Address: 1 Francis Crick Avenue Cambridge Biomedical Campus Cambridge CB2 0AA, U.K. Tel: +44-(0)20-3749-5000 Web: www.astrazeneca.com
Company Overview
AstraZeneca is a U.K.-based biopharmaceutical company. The company operates in three segments and is focused on our chosen therapy areas: Oncology, Biopharmaceuticals, and rare diseases. The Biopharmaceuticals segment comprises therapeutic areas, including cardiovascular, renal, and metabolism (CVRM), respiratory and immunology (R&I), and vaccines and immune therapies (V&I). The company’s products are sold in over 125 countries.
The company’s R&D focuses on bispecific, inhaled fragments, ADCs, and cell-depleting monoclonal antibodies in antibody therapeutics.
The major brands are Forxiga or Farxiga, Ebymect, Edistride, Xigduo, Bydureon, Lynparza, Bydureon, Xigduo, Edistride, and Ebymect.
Company's Business Segments
- Oncology : Cancer
- Rare Disease : Hypophosphatasia (HPP), Neurofibromatosis Type 1 (NF1) Plexiform Neurofibromas (PN), Wilson disease, and Rare cancers.
- Other Medicines : Cardiovascular (CV), Renal & Metabolism, Respiratory & Immunology, and Vaccines & Immune Therapies.
Applications/End User Industries
- Oncology
- Cardiovascular
- Renal
- Metabolism
- Respiratory and Immunology (R&I)
- Vaccines and Immune Therapies (V&I)
- Rare Disease
BCC Research Beacon 